COMPANIES COVERED
TakedaDownload FREE Report Sample
Download Free sampleImmune globulin?(Ig) short-term protection against hepatitis A and measles
Human Immune Globulin Intravenous Market contains market size and forecasts of Human Immune Globulin Intravenous in global, including the following market information:
Global Human Immune Globulin Intravenous Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Immune Globulin Intravenous Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Human Immune Globulin Intravenous companies in 2021 (%)
The global Human Immune Globulin Intravenous market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
IVIg Liquid Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Immune Globulin Intravenous include Takeda, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG and Shanghai RAAS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Immune Globulin Intravenous manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Immune Globulin Intravenous Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Immune Globulin Intravenous Market Segment Percentages, by Type, 2021 (%)
IVIg Liquid
IVIg Powder
Global Human Immune Globulin Intravenous Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Immune Globulin Intravenous Market Segment Percentages, by Application, 2021 (%)
Immunodeficiency
Autoimmune Disease
Acute Infection
Global Human Immune Globulin Intravenous Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Immune Globulin Intravenous Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Immune Globulin Intravenous revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Immune Globulin Intravenous revenues share in global market, 2021 (%)
Key companies Human Immune Globulin Intravenous sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Human Immune Globulin Intravenous sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
